home.social

#takeda — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #takeda, aggregated by home.social.

  1. Takeda Pharmaceutical's newly appointed CEO Julie Kim says the company will return to growth in two to three years as it gears up for a wave of product launches. japantimes.co.jp/business/2026 #business #companies #takeda #pharmaceuticals #us #ai

  2. Takeda Pharmaceutical's newly appointed CEO Julie Kim says the company will return to growth in two to three years as it gears up for a wave of product launches. japantimes.co.jp/business/2026 #business #companies #takeda #pharmaceuticals #us #ai

  3. A U.S. jury found Japan-based Takeda Pharmaceutical liable for causing about $885 million in damages by delaying a generic version of its constipation drug Amitiza via an anticompetitive scheme. japantimes.co.jp/business/2026 #business #companies #us #medicine #takeda #pharmaceuticals #health

  4. A U.S. jury found Japan-based Takeda Pharmaceutical liable for causing about $885 million in damages by delaying a generic version of its constipation drug Amitiza via an anticompetitive scheme. japantimes.co.jp/business/2026 #business #companies #us #medicine #takeda #pharmaceuticals #health

  5. BREAKING: Takeda Pharma (TSE:4502) trades 6.7% OVERVALUED at ¥5,614 despite 28.4% quarterly surge 📈 - EXCLUSIVE Feb 16 data shows analysts split (¥4,500-¥5,900 targets). Reddit investors demand proof of "60% upside" claims as fair value line breaks. Is this the top? Full analysis 🔽 [Link] #Takeda #PharmaStocks #Valuation #Investing #JapanStocks

    🔗 Full Story: talknation.site/2026/02/assess

    #news #tech #talknation

  6. BREAKING: Takeda Pharma (TSE:4502) trades 6.7% OVERVALUED at ¥5,614 despite 28.4% quarterly surge 📈 - EXCLUSIVE Feb 16 data shows analysts split (¥4,500-¥5,900 targets). Reddit investors demand proof of "60% upside" claims as fair value line breaks. Is this the top? Full analysis 🔽 [Link] #Takeda #PharmaStocks #Valuation #Investing #JapanStocks

    🔗 Full Story: talknation.site/2026/02/assess

    #news #tech #talknation

  7. alojapan.com/1449615/takeda-ky Takeda, Kyoto University end 10-year stem cell tie-up, with no new drugs #10Year #cell #drugs #end #Kyoto #KyotoNews #new #news #no #STEM #takeda #TieUp #university #京都 #京都府 Kyoto University professor Shinya Yamanaka, left, and Takeda Pharmaceutical President Christophe Weber after their news conference in Tokyo on Feb. 3. (Photo by Nanami Sato) TAITO KUROSE, HINAKO BANNO and YASUKI OKAMOTO February 4, 2026 01:12 JST TOKYO/OSAKA — Japan’s Tak

  8. alojapan.com/1449615/takeda-ky Takeda, Kyoto University end 10-year stem cell tie-up, with no new drugs #10Year #cell #drugs #end #Kyoto #KyotoNews #new #news #no #STEM #takeda #TieUp #university #京都 #京都府 Kyoto University professor Shinya Yamanaka, left, and Takeda Pharmaceutical President Christophe Weber after their news conference in Tokyo on Feb. 3. (Photo by Nanami Sato) TAITO KUROSE, HINAKO BANNO and YASUKI OKAMOTO February 4, 2026 01:12 JST TOKYO/OSAKA — Japan’s Tak

  9. Takeda, Kyoto University end fruitless stem cell drug search after 10 years

    Kyoto University professor Shinya Yamanaka, left, and Takeda Pharmaceutical President Christophe Weber after their news conference in Tokyo on Feb. 3. (Photo by Nanami Sato) TAITO KUROSE, HINAKO …
    #Japan #JP #Kyoto #10 #cell #drug #end #fruitless #kyotonews #news #search #STEM #takeda #university #year's #京都 #京都府
    alojapan.com/1449583/takeda-ky

  10. alojapan.com/1449583/takeda-ky Takeda, Kyoto University end fruitless stem cell drug search after 10 years #10 #cell #drug #end #fruitless #Kyoto #KyotoNews #news #search #STEM #takeda #university #year's #京都 #京都府 Kyoto University professor Shinya Yamanaka, left, and Takeda Pharmaceutical President Christophe Weber after their news conference in Tokyo on Feb. 3. (Photo by Nanami Sato) TAITO KUROSE, HINAKO BANNO and YASUKI OKAMOTO February 4, 2026 01:12 JST TOKYO/OSAKA — Ja

  11. Takeda Pharmaceutical announced that its oral psoriasis drug zasocitinib proved safe and effective in late-stage trials, marking a milestone in its effort to treat the incurable skin condition. japantimes.co.jp/news/2025/12/ #japan #medicine #ai #takeda

  12. Takeda Pharmaceutical announced that its oral psoriasis drug zasocitinib proved safe and effective in late-stage trials, marking a milestone in its effort to treat the incurable skin condition. japantimes.co.jp/news/2025/12/ #japan #medicine #ai #takeda

  13. Takeda’s dengue vaccine has demonstrated strong protection against infection and hospitalization for seven years, marking the longest efficacy reported among any available dengue vaccines. japantimes.co.jp/business/2025 #business #companies #takeda #pharmaceuticals #health #denguefever #vaccinations

  14. Takeda’s dengue vaccine has demonstrated strong protection against infection and hospitalization for seven years, marking the longest efficacy reported among any available dengue vaccines. japantimes.co.jp/business/2025 #business #companies #takeda #pharmaceuticals #health #denguefever #vaccinations

  15. Takeda’s dengue vaccine has demonstrated strong protection against infection and hospitalization for seven years, marking the longest efficacy reported among any available dengue vaccines. japantimes.co.jp/business/2025 #business #companies #takeda #pharmaceuticals #health #denguefever #vaccinations

  16. Takeda Pharmaceutical’s experimental narcolepsy drug has significantly improved outcome for patients in late-stage clinical trials, and could become the first treatment to target the disorder's root cause. japantimes.co.jp/news/2025/09/ #japan #sciencehealth #takeda #health #pharmaceuticals #sleep

  17. Takeda Pharmaceutical’s experimental narcolepsy drug has significantly improved outcome for patients in late-stage clinical trials, and could become the first treatment to target the disorder's root cause. japantimes.co.jp/news/2025/09/ #japan #sciencehealth #takeda #health #pharmaceuticals #sleep

  18. Local pharmaceutical exec gets nearly 4 years for defrauding company; has to give up Seaport condo, Mercedes, 2-carat engagement ring and deposit on a downtown wedding venue
    universalhub.com/2024/local-ph

    #Brookline #Takeda #crime

  19. Local pharmaceutical exec gets nearly 4 years for defrauding company; has to give up Seaport condo, Mercedes, 2-carat engagement ring and deposit on a downtown wedding venue
    universalhub.com/2024/local-ph

    #Brookline #Takeda #crime

  20. Japan's biggest drugmaker, Takeda Pharmaceutical, beat estimates for second-quarter profit and lifted its full-year earnings forecast as it restructures to cut costs. japantimes.co.jp/business/2024 #business #takeda #pharmaceuticals

  21. Japan's biggest drugmaker, Takeda Pharmaceutical, beat estimates for second-quarter profit and lifted its full-year earnings forecast as it restructures to cut costs. japantimes.co.jp/business/2024 #business #takeda #pharmaceuticals

  22. Lilly inks $3.2B Morphic buyout to snag oral rival to Takeda's IBD blockbuster—GLP-1s may cut risk of 10 obesity-related cancers in diabetics —Study finds Pfizer's RSV vaccine not tied to higher risk of pre-term births —bit.ly/w28kSd #mergersandacquistions #elililly #ibd #takeda #glp1 #novonordisk #diabetes #cancer #pfizer #rsv #vaccines #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  23. GLP-1 global obesity market to reach $111B by 2033, despite headwinds—Takeda circles leukemia rival to Novartis' Scemblix in up to $1.3B deal with Ascentage —J.P. Morgan's private financing arm closes inaugural $500M-plus biotech fund—bit.ly/w28kSd #obesity #glp1 #novonordisk #elililly #novartis #takeda #vml #funding #jpmorgan #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  24. Takeda joins hot molecular glue market with $1.2B deal—AstraZeneca pays $19M to Harbour BioMed's Nona for preclinical cancer antibodies —Pfizer expands cost cuts with new $1.5B target --bit.ly/w28kSd #takeda #molecularglue #astrazeneca #pfizer #layoffs #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  25. BIOSECURE Act gets update, gives US drugmakers until 2032 to sever ties with Chinese biotechs—Sanofi pays $80M to add Roche-rivaling Fulcrum drug to phase 3 rare disease pipeline —Takeda wagers up to $2.2bn on AC Immune Alzheimer’s shot --bit.ly/w28kSd #biosecureact #china #legislation #Sanofi #takeda #alzheimers #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  26. Keytruda strikes out again in endometrial cancer with phase III flop—Novo inks $600M deal with Metaphore to develop next-gen obesity drugs —Takeda Pharma to restructure after annual profit slump --bit.ly/w28kSd #merck #keytruda #endometrialcancer #clinicaltrials #novonordisk #obesity #drugdevelopment #takeda #restructuring #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  27. @faraiwe yes I’m aware #DaitoRyu #Takeda practised Ono Ha #IttoRyu #kenjutsu. What’s less clear is if he ever taught #aikido founder Ueshiba the Itto Ryu stuff. I would welcome any valid sources that would state that as it would be quite new insight.

    The bokken I use in Ono Ha Itto Ryu is not, btw, the same as Iwama bokken. It is thick, yes, and relatively straight, but has a pointy end.

  28. @faraiwe yes I’m aware #DaitoRyu #Takeda practised Ono Ha #IttoRyu #kenjutsu. What’s less clear is if he ever taught #aikido founder Ueshiba the Itto Ryu stuff. I would welcome any valid sources that would state that as it would be quite new insight.

    The bokken I use in Ono Ha Itto Ryu is not, btw, the same as Iwama bokken. It is thick, yes, and relatively straight, but has a pointy end.

  29. @faraiwe yes I’m aware #DaitoRyu #Takeda practised Ono Ha #IttoRyu #kenjutsu. What’s less clear is if he ever taught #aikido founder Ueshiba the Itto Ryu stuff. I would welcome any valid sources that would state that as it would be quite new insight.

    The bokken I use in Ono Ha Itto Ryu is not, btw, the same as Iwama bokken. It is thick, yes, and relatively straight, but has a pointy end.

  30. @faraiwe yes I’m aware #DaitoRyu #Takeda practised Ono Ha #IttoRyu #kenjutsu. What’s less clear is if he ever taught #aikido founder Ueshiba the Itto Ryu stuff. I would welcome any valid sources that would state that as it would be quite new insight.

    The bokken I use in Ono Ha Itto Ryu is not, btw, the same as Iwama bokken. It is thick, yes, and relatively straight, but has a pointy end.

  31. @faraiwe yes I’m aware #DaitoRyu #Takeda practised Ono Ha #IttoRyu #kenjutsu. What’s less clear is if he ever taught #aikido founder Ueshiba the Itto Ryu stuff. I would welcome any valid sources that would state that as it would be quite new insight.

    The bokken I use in Ono Ha Itto Ryu is not, btw, the same as Iwama bokken. It is thick, yes, and relatively straight, but has a pointy end.

  32. Pharma CEOs, pressed by Senate panel, refuse to commit to price cuts—Takeda pushes one narcolepsy program into phase III, discontinues another — Moderna shares slide as longer-term data shows quick fall in RSV vaccine efficacy--bit.ly/w28kSd #senate #ceos #drugpricing #berniesanders #takeda #clinicaltrials #narcolepsy #moderna #rsv #vaccines #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  33. Musste heute in der Apotheke erfahren, dass eines meiner #Medikamente nicht lieferbar ist.
    Entgegen der aktuellen Meldungen in der Presse sind allerdings überhaupt keine Dosen mehr lieferbar und es ist nicht bekannt, wann die Tabletten wieder #lieferbar sein werden.
    Eine Alternative oder Generika gibt es nicht.
    Das wird jetzt für viele und mich eine wilde Zeit 🥴😵‍💫🫨🤪 ohne #Intuniv 😖

    Danke #Gesundheitssystem #Lauterbach #Takeda GmbH 😡

    news.de/gesundheit/857188434/i

  34. Musste heute in der Apotheke erfahren, dass eines meiner #Medikamente nicht lieferbar ist.
    Entgegen der aktuellen Meldungen in der Presse sind allerdings überhaupt keine Dosen mehr lieferbar und es ist nicht bekannt, wann die Tabletten wieder #lieferbar sein werden.
    Eine Alternative oder Generika gibt es nicht.
    Das wird jetzt für viele und mich eine wilde Zeit 🥴😵‍💫🫨🤪 ohne #Intuniv 😖

    Danke #Gesundheitssystem #Lauterbach #Takeda GmbH 😡

    news.de/gesundheit/857188434/i

  35. CW: Neurodivergence, medication, food

    Began my day at 5:45am with usual 200mg #Pristiq and commenced #Vyvanse 30mg. Oddly reassured by name of pharmaceutical company, #Takeda. Thank you interest in Japanese history for this irrational positive bias.

    I followed this with my standard breakfast of 1 double shot flat white on BonSoy, muesli with fresh apple and BonSoy, then another double shot flat white on BonSoy.

    No notable interaction between #SNRI and stimulant medications so far but slightly bitter taste in my mouth; a quick interweb search tells me this is not uncommon for Vyvanse.

  36. Hoor net dat #Takeda #B12 wél beschikbaar is maar niet leverbaar in NL 'dankzij' @MinVWS @ministerVWS 😡

    "Takeda levert dus niet aan de Nederlandse markt,omdat de NL vergoedingen het laagste van Europa zijn."

    Waarvoor betalen we nog #ZorgVerzekering?
    #UitgesteldeZorg #Medicatie